5. Segment information
Geographical information
We are currently operating as a single operating segment. Prior to the disposal of Fidelta in 2021 we had two reportable segments: R&D and fee-for-service business.
In 2022 our operations were mainly located in Belgium, France, the Netherlands, Germany, Italy, Spain, Switzerland and the United Kingdom. The revenues from our collaboration partner Gilead represented 82% of our total net revenues in 2022 (97% in 2021).
In 2022 we reported €87.6 million of product net sales for Jyseleca® in Europe (€14.8 million in 2021) of which €7.3 million realized in Belgium (€1.7 million in 2021).
Following table summarizes our collaboration revenues by destination of customer:
|
Year ended 31 December |
|
|---|---|---|
(thousands of €) |
2022 |
2021 |
United States of America |
414,129 |
467,978 |
Europe |
3,552 |
2,114 |
Total collaboration revenues |
417,681 |
470,093 |
Following table summarizes our collaboration revenues by major customers:
|
Year ended 31 December |
|||
|---|---|---|---|---|
|
2022 |
2021 |
||
|
(thousands of €) |
% |
(thousands of €) |
% |
Gilead |
|
|
|
|
United States of America |
414,129 |
100% |
467,978 |
100% |
Europe |
1,452 |
0% |
2,071 |
0% |
Total collaboration revenues from major customers |
415,581 |
99% |
470,049 |
100% |
On 31 December 2022, we held €370.4 million (€197.6 million in 2021) of property, plant and equipment, intangible assets and goodwill distributed as follows:
|
31 December |
|
|---|---|---|
(thousands of €) |
2022 |
2021 |
Belgium |
72,087 |
98,295 |
France |
20,397 |
21,051 |
The Netherlands |
255,461 |
66,621 |
Switzerland |
4,962 |
7,181 |
Spain |
3,037 |
3,029 |
United States of America |
12,729 |
136 |
Other |
1,747 |
1,302 |
Total |
370,420 |
197,615 |